Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Record number of central banks plan to increase gold holdings amid global volatility

      Investors have been piling into gold for several reasons (Photo by Chris McGrath/Getty Images)

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Children as young as 14 are being targeted by unregulated gambling firms on social media

      Unfortunately, without additional context from the article or details about what the image depicts, it is challenging to g...

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Old Pulteney releases 50-year-old whisky for 200th anniversary

      Old Pulteney 50-Year-Old single malt Scotch whisky bottle with elegant packaging on display, highlighting luxury and craft...

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Wednesday 03 December 2014 10:28 am  |  Updated:  Friday 07 June 2019 5:45 pm

Parkinson’s app uMotif is the first app to be prescribed on the NHS

By: Emma Haslett

Add as a preferred source on Google

The NHS has just started prescribing its first app – from now on, patients with conditions such as diabetes, heart failure and Parkinsons can use uMotif, developed by a London-based startup, to monitor their health,

The app works by monitoring patients' blood pressure, blood glucose – and even includes a pedometer. Using the data it gets from them, it can issue patients with reminders, and help doctors to assess how well they are doing between appointments. To get access to it, patients are given a code on their prescription, and they can then download it from the iTunes or Android app store.

With the popularity of apps like MyFitnessPal, not to mention FitBug-style activity trackers, the logging of daily activity has become a pretty common thing. uMotif chief executive Bruce Hellman said we're at the "tipping point where digital health is about to start exploding and technology can really help to put people at the heart of their care".

At the moment, the app is being trialled for treatment of Parkinson's and diabetes, but it will be widened out across 17 NHS organisations. The idea is that it helps clinicians to develop on the NHS National Information Board's plans to "put patents at the centre of their care using technology" (although we'd hope patients were at the centre of their care already…).

The app can even link in with other healthcare applications, like Microsoft HealthVault. So following that £12bn IT bungle which crippled the NHS back in 2011, it looks like the service is finally getting its teeth into technology…

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NHS

Trending Articles

  • As it happened: FTSE 100 relief rally runs out of steam as BP and Shell weigh; Oil hits three-month low

  • London Tech Week sums up everything wrong with UK tech

  • Rolls-Royce shares surge as SMR unit bags multi-billion pound Swedish nuclear contract

  • Rathbones to suspend thousands of client account inflows after FCA probe deals £530m blow

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

More from CityAM

  • Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences

    Business Wire
  • Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • CellCentric Announces Oversubscribed $220 Million Series D Financing to Advance Pivotal Trials of Inobrodib in Multiple Myeloma

    Business Wire
  • NHS gives Palantir wider access to patient data amid growing backlash

    Tech
    NHS healthcare professionals in a hospital setting discussing patient care plans, wearing uniforms and medical equipment v...
  • Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited